Engineered biosynthesis of pimaricin derivatives with improved antifungal activity and reduced cytotoxicity
Engineered biosynthesis of pimaricin derivatives with improved antifungal activity and reduced cytotoxicity
复制标题
具有改善抗真菌活性和降低细胞毒性的匹马星衍生物的工程生物合成
DOI:
10.1007/s00253-015-6635-9
复制
发表时间:
2015-08-01
影响因子:
5
通讯作者:
Bai, Linquan
中科院分区:
文献类型:
--
作者:
Qi, Zhen;Kang, Qianjin;Bai, Linquan
Pimaricin is an important antifungal antibiotic for antifungal therapy and prevention of mould contamination in the food industry. In this study, three new pimaricin derivatives, 12-decarboxy-12-methyl pimaricin (1), 4,5-desepoxy-12-decarboxy-12-methyl pimaricin (2), and 2-hydro-3-hydroxy-4,5-desepoxy-12-decarboxy-12-methyl pimaricin (3), were generated through the inactivation of P450 monooxygenase genescnGinStreptomyces chattanoogensisL10. Compared with pimaricin,1displayed a twofold increase in antifungal activity againstCandida albicansATCC 14053 and a 4.5-fold decrease in cytotoxicity with erythrocytes, and2had comparable antifungal activity and reduced cytotoxicity, whereas3showed nearly no antifungal and hemolytic activities. Genetic and biochemical analyses proved that1is converted from2by P450 monooxygenase ScnD. Therefore, the overexpression ofscnDinscnG-null strain eliminated the accumulation of2and improved the yield of1by 20 %. Conversely,scnG/scnDdouble mutation abolished the production of1and improved the yield of2to 2.3-fold. These results indicate that the pimaricin derivatives with improved pharmacological properties obtained by genetic engineering can be further developed into antifungal agents for potential clinical application.